NLS LIF

The three trade organizations LIF, Swedish Medtech and SwedenBIO have presented a common action plan for life science. The plan consists of 25 steps to strengthen Sweden’s competitiveness. For six months the trade organizations have worked to bring out the action plan which was presented on October 21. The organizations state that the Swedish government […]

LIF, the trade association for the research-based pharmaceutical industry in Sweden, emphazises the pharmaceutical industry’s economic role in Sweden in a new report. The report Vinst för Sverige – Den forskande läkemedelsbranschens betydelse för samhället (Profit for Sweden – the research-based pharmaceutical industry’s importance for society) was presented on June 30 during the Almedalen Week, […]

Maria Fagerquist will be the new Vice Director of the Swedish trade association for the research-based pharmaceutical industry. She will assume office by the end of June 2014. Fagerquist has previously worked as Head of European Public Affairs at Novartis Oncology in Brussels. She has also worked at Pfizer and the Dental and Pharmaceutical Benefits Agency. “I […]

Public healthcare and the pharma, medtech and laboratory technical industries get new collaboration rules. Swedish Medtech has entered an agreement with the Swedish Association of Local Authorities and Regions, the trade association for the research-based pharmaceutical industry (LIF) and Swedish Labtech about the collaboration rules. The new agreement describes the parties view on product and […]

Not only in the Nordic countries, but also in the rest of Europe, pharmaceutical companies are choosing to locate their R&D activities in emerging markets. What are the drug company strategies and what effect will the ongoing outsourcing trend have on the industry? China India, Russia, and South American countries such as Brazil, are highly […]